Hasegawa Hitoshi

ハセガワヒトシ | Hasegawa Hitoshi

Affiliation and department：

Research field (1)： Allergies and connective tissue disease

Research keywords (6)：リウマチ・膠原病 , 感染症 , 内科 , Molecular Biology , Infection , Internal Medicine

Research theme for competitive and other funds (15)：

Show all

Papers (61)：

Masahiro Okada, Koichiro Suemori, Daiki Takagi, Masato Teraoka, Hiroyuki Yamada, Jun Ishizaki, Takuya Matsumoto, Hitoshi Hasegawa, Naohito Hato. The treatment outcomes of rituximab for intractable otitis media with ANCA-associated vasculitis. Auris, nasus, larynx. 2019. 46. 1. 38-42
Akinori Hara, Takashi Wada, Ken-Ei Sada, Koichi Amano, Hiroaki Dobashi, Masayoshi Harigai, Yoshinari Takasaki, Hidehiro Yamada, Hitoshi Hasegawa, Taichi Hayashi, et al. Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis in Japan: A nationwide, prospective cohort study. Journal of Rheumatology. 2018. 45. 4. 521-528
Hitoshi Hasegawa, Takuya Matsumoto. Mechanisms of tolerance induction by dendritic cells in vivo. Frontiers in Immunology. 2018. 9. 350
Takemasa E, Liu S, Hasegawa H. Production of Neutralizing Antibody. Methods in molecular biology (Clifton, N.J.). 2018. 1868. 79-92
Hasegawa H. Design an Intervention Study. Methods in molecular biology (Clifton, N.J.). 2018. 1868. 235-241

ｍore...

MISC (112)：

ｍore...

Books (5)：

血管炎(第2版)
日本臨床社 2018
今日の治療指針2017
医学書院 2017
リウマチ病学テキスト(改訂第2版)
診断と治療社 2016
膠原病・リウマチ・アレルギー研修ノート
診断と治療社 2016
CCR7 chemokine receptor expression on normal lymphocyte subsets and adult T-cell leukemia cells
Leucocyke typing VII 2002

Education (4)：

Professional career (1)：

Work history (6)：

Show all

Association Membership(s) (6)：

THE JAPAN SOCIETY FOR CLINICAL IMMUNOLOGY , THE JAPANESE SOCIETY FOR IMMUNOLOGY , 日本リウマチ学会 , 日本感染症学会 , 日本ウイルス学会 , 日本内科学会

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page